Euscaphic acid exhibits significant anti-inflammatory and hepatoprotective properties, making it valuable in the development of natural therapeutic agents for liver disorders. It has been studied for its ability to inhibit key inflammatory mediators such as nitric oxide and prostaglandin E2, suggesting potential use in treating chronic inflammatory conditions. Additionally, euscaphic acid demonstrates anticancer activity by inducing apoptosis in certain tumor cell lines, particularly in liver and colon cancer models. Its role in modulating cellular signaling pathways, including NF-κB and MAPK, further supports its application in pharmacological research targeting cancer and metabolic diseases. Due to its natural origin and low toxicity, it is also explored as a lead compound in nutraceuticals and functional food additives aimed at promoting liver health and preventing oxidative stress-related damage.